- Home
- FEMY vs GENK Comparison
FEMY vs GENK Comparison
Compare FEMY & GENK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FEMY
- GENK
- Stock Information
- Founded
- FEMY 2004
- GENK 2011
- Country
- FEMY United States
- GENK United States
- Employees
- FEMY N/A
- GENK N/A
- Industry
- FEMY Medical/Dental Instruments
- GENK Restaurants
- Sector
- FEMY Health Care
- GENK Consumer Discretionary
- Exchange
- FEMY Nasdaq
- GENK Nasdaq
- Market Cap
- FEMY 31.9M
- GENK 20.4M
- IPO Year
- FEMY 2021
- GENK 2023
- Fundamental
- Price
- FEMY $0.91
- GENK $3.81
- Analyst Decision
- FEMY Strong Buy
- GENK Strong Buy
- Analyst Count
- FEMY 3
- GENK 2
- Target Price
- FEMY $8.67
- GENK $10.00
- AVG Volume (30 Days)
- FEMY 282.0K
- GENK 49.6K
- Earning Date
- FEMY 08-07-2025
- GENK 07-30-2025
- Dividend Yield
- FEMY N/A
- GENK 0.79%
- EPS Growth
- FEMY N/A
- GENK N/A
- EPS
- FEMY N/A
- GENK N/A
- Revenue
- FEMY $1,699,232.00
- GENK $214,957,000.00
- Revenue This Year
- FEMY $231.84
- GENK $17.79
- Revenue Next Year
- FEMY $245.28
- GENK $15.87
- P/E Ratio
- FEMY N/A
- GENK N/A
- Revenue Growth
- FEMY 61.97
- GENK 14.40
- 52 Week Low
- FEMY $0.69
- GENK $3.16
- 52 Week High
- FEMY $1.80
- GENK $10.33
- Technical
- Relative Strength Index (RSI)
- FEMY 50.88
- GENK 47.86
- Support Level
- FEMY $0.90
- GENK $3.72
- Resistance Level
- FEMY $0.99
- GENK $3.98
- Average True Range (ATR)
- FEMY 0.07
- GENK 0.22
- MACD
- FEMY 0.01
- GENK 0.02
- Stochastic Oscillator
- FEMY 39.48
- GENK 51.36
About FEMY Femasys Inc.
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.
About GENK GEN Restaurant Group Inc.
GEN Restaurant Group Inc operates an Asian casual dining restaurant chain, offering an extensive menu of traditional Korean and Korean-American food, including high-quality meats, poultry, seafood, and mixed vegetables. It operates 43 Gen Korean BBQ restaurants in the United States.